Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2004-08-10
2010-06-29
Vivlemore, Tracy (Department: 1635)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023100, C514S04400A
Reexamination Certificate
active
07745608
ABSTRACT:
The invention relates to iRNA agents, which preferably include a monomer in which the ribose moiety has been replaced by a moiety other than ribose. The inclusion of such a monomer can allow for modulation of a property of the iRNA agent into which it is incorporated, e.g., by using the non-ribose moiety as a point to which a ligand or other entity, e.g., a lipophilic moiety. e.g., cholesterol, is directly, or indirectly, tethered. The invention also relates to methods of making and using such modified iRNA agents.
REFERENCES:
patent: 5328470 (1994-07-01), Nabel et al.
patent: 5519134 (1996-05-01), Acevedo et al.
patent: 5646126 (1997-07-01), Cheng et al.
patent: 6509323 (2003-01-01), Davis et al.
patent: 2003/0008818 (2003-01-01), Pun et al.
patent: 2003/0170891 (2003-09-01), McSwiggen
patent: WO9203464 (1992-03-01), None
patent: WO 00/44895 (2000-08-01), None
patent: WO 00/44914 (2000-08-01), None
patent: WO 01/36646 (2001-05-01), None
patent: WO 01/75164 (2001-10-01), None
patent: WO 02/44321 (2002-06-01), None
Opalinska et al. Nature Reviews Drug Discovery, 2002, vol. 1, p. 503-514.
Amosova et al., “Effect of the 1-(2'-deoxy-beta-D-ribofuranosyl)-3-nitropyrrole residue on the stability of DNA duplexes and triplexes”Nucleic Acids Res.25:1930-1934 (1997).
Aoki et al., “Potential tumor-targeting pepetide vector of histidylated oligolysine conjugated to a tumor-homing RGD MOTIF”Cancer Gene Therpy8:783-787 (2001).
Ausin et al., “Synthesis of Amino- and Guanidino-G-Clamp PNA Monomers”Organic Letters4:4073-4075 (2002).
Berger et al., “Universal bases for hybridization, replication and chain termination”Nucleic Acids Res.28:2911-2914 (2000).
Bergstrom et al., “Synthesis, Structure, and Deoxyribonucleic Acid Sequencing with a Universal Nucleoside: 1-(2'-Deoxy-β-D-ribofuranosyl)-3-nitropyrrole”Am. Chem. Soc.117:1201-1209 (1995).
Bernstein et al., “Role for a bidentate ribonuclease in the initiation step of RNA interference”Nature409:363-366 (2001).
Brotschi et al., “A Stable DNA Duplex Containing a Non-Hydrogen-Bonding and Non-Shape-Complementary Base Couple: Interstrand Stacking as the Stability Determining Factor”Agnew Chem. Int. Ed.40:3012-3014 (2001).
Chen et al., “Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo”Proc. Natl. Acad. Sci. USA91:3054-3057 (1994).
Colledge et al., “Disruption of c-mos causes parthenogenetic development of unfertilized mouse eggs”Nature370: 65-68 (1994).
Cormier et al., “Synthesis of hexanucleotide analogues containing diisopropylsilyl internucleotide linkages”Nucleic Acids Res.16:4583-4594 (1988).
Edge et al., “Synthetic Analogues of Polynucleotides. Part VIII. Analogues of Oligonucleotides containing Carboxymethylthymidine”J. Chem. Soc. Perkin Trans.1:1991-1996 (1972).
Elbashir et al., “RNA interference is mediated by 21-and 22- nucleotide RNAs”Genes and Dev.15:188-200 (2001).
Fire et al., “Potent specific genetic interference by double-stranded RNA inCaenorhabditis elegans”Nature391:806-811 (1998).
Flanagan et al., “A cytosine analog that confers enhanced potency to antisense oligonucleotides”Proc. Natl. Acad. Sci. USA96:3513-3518 (1999).
Gante, “Azapeptides”Synthesis405-413 (1989).
Guckian et al., “Structure and Base Pairing Properties of a Replicable Nonpolar Isostere for Deoxyadenosine”J. Org. Chem.63:9652-9656 (1998).
Hammond et al., “Argonaute2, a link between genetic and biochemical analyses of RNAi”Science293:1146-1150 (2001).
Hashimoto et al., “Parthenogenetic activation of oocytes in c-mos-deficient mice”Nature370:68-71 (1994).
Haubner et al., “Glycosylated RGD-Containing Peptides: Tracer for Tumor Targeting and Angiogenesis Imaging with Improved Biokinetcs”J. Nucl. Med.42:326-336 (2001).
Holmes et al., “Steric inhibition of human immunodeficiency virus type-1 Tat-dependent trans-activation in vitro and in cells by oligonucleotides containing 2'-O-methyl G-clamp ribonucleoside analogues”Nucleic Acids Res.31:2759-2768 (2003).
Holmes et al., “The Synthesis of 2'-O-Methyl G-Clamp Containing Oligonucleotides and Their Inhibition of the HIV-1 Tat-TAR Interaction,”Nucleosides, Nucleotides & Nucleic Acids22:1259-1262 (2003).
Iyer et al., “3H-1,2-Benzodithiole-3-one 1,1-Dioxide as an Improved Sulfurizing Reagent in the Solid-Phase Synthesis of Oligodeoxyribonucleoside Phosphorothioates”J. Am. Chem. Soc.112:1253-1254 (1990).
Katajisto et al., “Solid-Phase Synthesis of Multiantennary Oligonucleotide Glycoconjugates Utilizing On-Support Oximation”Bioconjugate Chem.15:890-896 (2004).
Kawasaki et al., “Uniformly Modified 2'-Deoxy-2'-fluoro Phosphorothioate Oligonucleotides as Nuclease-Resistant Antisense Compounds with High Affinity and Specificity for RNA Targets”J. Med. Chem.36:831-841 (1993).
Ketting et al., “Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans”Genes Dev.15:2654-2659 (2001).
Kumar et al., “Express Protocol for Functionalization of Polymer Supports for Oligonucleotide Synthesis”Nucleosides&Nucleotides15:879-888 (1996).
Lam et al., “A new type of synthetic peptide library for identifying ligand-binding activity”Nature354:82-84 (1991).
Lan et al., “Minor Groove Hydration is Critical to the Stability of DNA Duplexes”J. Am. Chem. Soc.122:6512-6513 (2000).
Larock, “Table of Contents fromComprehensive Organic Transformation” VCH Publishers, Inc. (1989).
Limbach et al., “Summary: the modified nucleosides of RNA”Nucleic Acids Res.22:2183-2196 (1994).
Liu et al., “Bi-stranded, multisite replication of a base pair between difluorotoluene and adenine: confirmation by ‘inverse’ sequencing”Chem. Biol.4:919-926 (1997).
Loakes, “The applications of universal DNA base analogues”NAR29:2437-2447 (2001).
Maier et al., “Nuclease resistance of oligonucleotides containing the tricyclic cytosine analogues phenoxazine and 9-(2-aminoethoxy)-phenoxazine (“G-clamp”) and origins of their nuclease resistance properties”Biochem.41:1323-1327 (2002).
Manoharan et al., “Oligonucleotide Conjugates as Potential Antisense Drugs with Improved Uptake, Biodistribution, Targeted Delivery, and Mechanism of Action”Antisense and Nucleic Acid Drug Development12:103-128 (2002).
Martin, “Stereoselektive Synthese von 2'-O-(2-Methoxyethyl)ribonucleosiden: Nachbargruppenbeteiligung der methyoxyethosy-Gruppe bei der Ribosylierung von Heterocyclen”Helv. Chim. Acta79:1930-1938 (1996) (in German), English Abstract Only.
Matray et al., “Selective and Stable DNA Base Pairing without Hydrogen Bonds”J. Chem. Soc.120:6191-6192 (1998).
McMinn et al., “Efforts toward Expansion of the Genetic Alphabet; DNA Polymerase Recognition of a Highly Stable, Self-Pairing Hydrophobic Base”J. Am. Chem. Soc.121:11585-11586 (1999).
Morales et al., “Importance of Terminal Base Pair Hydrogen-Bonding in 3'-End Proofreading by the Klenow Fragment of DNA Polyerasel”Biochem.39:2626-2632 (2000).
Moran et al., “Difluorotoluene, a Nonpolar Isotere for Thymine, Codes Specifically and Efficiently for Adenine in DNA Replication”J. Am. Chem. Soc.119:2056-2057 (1997).
Nakatani et at , “Recognition of a Single Guanine Bulge by 2-Acylamino-1, 8-naphthyridine”J. Am. Chem. Soc.122:2172-2177 (2000).
Nakatani et al., “Specific binding of 2-amino-1,8-naphthyridine into a single guanine bulge as evidenced by photooxidation of GG doublet”Bioorg. Med. Chem. Lett.11:335-337 (2001).
Noguchi et al. “Total Synthesis of Analogs of Topostin B, A DNA Topoisomerase I Inhibitor. Part 1. Synthesis of Fragme
Kesavan Venkitasamy
Manoharan Muthiah
Rajeev Kallanthottathil G.
Alnylam Pharmaceuticals, Inc.
Nixon & Peabody LLP
Townes Jeffrey N.
Vivlemore Tracy
LandOfFree
Modified iRNA agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified iRNA agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified iRNA agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4201303